IN THE NEWS: Where Do We Stand with DCTs Heading Into 2025?

Clinical Leader

As we approach a new year, Clinical Leader asked clinical trials professionals about the success and future outlook of using decentralized clinical trials (DCT). Wasif Saif, M.D., MBBS, medical oncologist and leader of the Phase I Clinical Trials Multidisciplinary Team at Karmanos, explained how DCTs have provided access to many cancer patients, and what should be considered when designing a trial.

Read the article here.

Wasif Saif, M.D., MBBS